{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:28Z","timestamp":1786119448355,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/qai.0b013e3181c190f4","type":"journal-article","created":{"date-parts":[[2010,1,22]],"date-time":"2010-01-22T03:35:41Z","timestamp":1264131341000},"page":"186-193","source":"Crossref","is-referenced-by-count":20,"title":["Insulin Sensitivity in Multiple Pathways Is Differently Affected During Zidovudine\/Lamivudine-Containing Compared With NRTI-Sparing Combination Antiretroviral Therapy"],"prefix":"10.1097","volume":"53","author":[{"given":"Marit G A","family":"van Vonderen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regje M E","family":"Bl\u00fcmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly A M","family":"Hassink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Sutinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette T","family":"Ackermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel A","family":"van Agtmael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannele","family":"Yki-Jarvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven A","family":"Danner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille J","family":"Serlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans P","family":"Sauerwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Reiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210131","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1097\/00002030-200111090-00004","article-title":"Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways.","volume":"15","author":"van der Valk","year":"2001","journal-title":"AIDS"},{"key":"R2-5-20210131","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200203290-00002","article-title":"Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study.","volume":"16","author":"Noor","year":"2002","journal-title":"AIDS"},{"key":"R3-5-20210131","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1086\/505974","article-title":"Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers.","volume":"43","author":"Lee","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R4-5-20210131","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200411050-00005","article-title":"The effects of HIV protease inhibitors atazanavir and lopinavir\/ritonavir on insulin sensitivity in HIV-seronegative healthy adults.","volume":"18","author":"Noor","year":"2004","journal-title":"AIDS"},{"key":"R5-5-20210131","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/01.aids.0000244200.11006.55","article-title":"Effects of atazanavir\/ritonavir and lopinavir\/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically.","volume":"20","author":"Noor","year":"2006","journal-title":"AIDS"},{"key":"R6-5-20210131","doi-asserted-by":"crossref","first-page":"E691","DOI":"10.1152\/ajpendo.00006.2006","article-title":"Insulin sensitivity is preserved despite disrupted endothelial function.","volume":"291","author":"Shankar","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R7-5-20210131","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00002030-200403050-00008","article-title":"The metabolic effects of lopinavir\/ritonavir in HIV-negative men.","volume":"18","author":"Lee","year":"2004","journal-title":"AIDS"},{"key":"R8-5-20210131","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/QAI.0b013e318189a780","article-title":"Antiretroviral therapy exposure and insulin resistance in the Womens Interagency HIV study.","volume":"49","author":"Tien","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-5-20210131","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1097\/QAD.0b013e32827038d0","article-title":"Antiretroviral therapy exposure and incidence of diabetes mellitus in the Womens Interagency HIV Study.","volume":"21","author":"Tien","year":"2007","journal-title":"AIDS"},{"key":"R10-5-20210131","doi-asserted-by":"crossref","first-page":"E1666","DOI":"10.1152\/ajpendo.00550.2006","article-title":"Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults.","volume":"292","author":"Fleischman","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R11-5-20210131","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/QAD.0b013e3282f33557","article-title":"Zidovudine\/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy.","volume":"22","author":"Blumer","year":"2008","journal-title":"AIDS"},{"key":"R12-5-20210131","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1210\/jc.2006-1518","article-title":"Chronic treatment with pioglitazone does not protect obese patients with diabetes mellitus type II from free fatty acid-induced insulin resistance.","volume":"92","author":"Serlie","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-5-20210131","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1210\/jc.2002-020892","article-title":"Highly active antiretroviral therapy-induced lipodystrophy has minor effects on human immunodeficiency virus-induced changes in lipolysis, but normalizes resting energy expenditure.","volume":"87","author":"van der Valk","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"R14-5-20210131","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.2337\/db06-S002","article-title":"Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction.","volume":"55","author":"Morino","year":"2006","journal-title":"Diabetes"},{"key":"R15-5-20210131","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1532-0456(03)00024-3","article-title":"Site-specific differences in the action of NRTI drugs on adipose tissue incubated in vitro with lymphoid cells, and their interaction with dietary lipids.","volume":"135","author":"Mattacks","year":"2003","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"R16-5-20210131","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2337\/diabetes.50.6.1425","article-title":"The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes.","volume":"50","author":"Rudich","year":"2001","journal-title":"Diabetes"},{"key":"R17-5-20210131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0166-3542(00)00102-9","article-title":"HIV protease inhibitors block adipogenesis and increase lipolysis in vitro.","volume":"47","author":"Lenhard","year":"2000","journal-title":"Antiviral Res"},{"key":"R18-5-20210131","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tips.2004.12.005","article-title":"Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity.","volume":"26","author":"Villarroya","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"R19-5-20210131","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/135965350701200407","article-title":"Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages.","volume":"12","author":"Lagathu","year":"2007","journal-title":"Antivir Ther"},{"key":"R20-5-20210131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00041433-200402000-00011","article-title":"Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of systemic steatosis.","volume":"15","author":"Balasubramanyam","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"R21-5-20210131","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2002-020795","article-title":"Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy.","volume":"88","author":"Addy","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-5-20210131","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00126334-200212150-00009","article-title":"Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution.","volume":"31","author":"Mynarcik","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R23-5-20210131","doi-asserted-by":"crossref","first-page":"E289","DOI":"10.1152\/ajpendo.00273.2005","article-title":"Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy.","volume":"290","author":"Hadigan","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R25-5-20210131","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00126334-200405010-00017","article-title":"HIV protease inhibitors increase adiponectin levels in HIV-negative men.","volume":"36","author":"Lee","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R26-5-20210131","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.","volume":"7","author":"Berg","year":"2001","journal-title":"Nat Med"},{"key":"R27-5-20210131","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11904-007-0019-4","article-title":"The role of protease inhibitors in the pathogenesis of HIV-associated insulin resistance: cellular mechanisms and clinical implications.","volume":"4","author":"Noor","year":"2007","journal-title":"Curr HIV \/AIDS Rep"},{"key":"R28-5-20210131","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11904-996-0008-z","article-title":"The effects of HIV protease inhibitors on carbohydrate and lipid metabolism.","volume":"2","author":"Lee","year":"2005","journal-title":"Curr HIV \/AIDS Rep"},{"key":"R29-5-20210131","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","article-title":"The mechanism of insulin resistance caused by HIV protease inhibitor therapy.","volume":"275","author":"Murata","year":"2000","journal-title":"J Biol Chem"},{"key":"R30-5-20210131","doi-asserted-by":"crossref","first-page":"55147","DOI":"10.1074\/jbc.M410826200","article-title":"A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity.","volume":"279","author":"Hertel","year":"2004","journal-title":"J Biol Chem"},{"key":"R31-5-20210131","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2337\/diabetes.52.4.918","article-title":"Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens.","volume":"52","author":"Woerle","year":"2003","journal-title":"Diabetes"},{"key":"R32-5-20210131","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/QAD.0b013e32832ba904","article-title":"Effects of switching from lopinavir\/ritonavir to atazanavir\/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients.","volume":"23","author":"Stanley","year":"2009","journal-title":"AIDS"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAI.0b013e3181c190f4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:19:37Z","timestamp":1786040377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201002010-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181c190f4","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}